Here, we have demonstrated that reduction in the expression of NF1 in two ovarian cancer cell lines results in activated MEK and ERK signalling, and is associated with decreased sensitivity to SRC inhibition. This evidence concerns the gene MAP2K7 and ovarian cancer.